Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Can Level 3 Interchange Rates Transform Your Margins Overnight?
-
Starting Small Checklist for Bulk Custom Phone Covers
-
China's Sichuan Extends Cultural Tourism Invitations at Global Landmarks
-
Global Sources Hong Kong Shows Phase II Officially Opens: AI Pavilion Debuts, Spotlighting Latest AI and Robotics Trends
-
Infrrd Announces the Official Launch of Ally: The First Agentic AI Workforce for Mortgage Auditing
-
Epomaker Unveils Magcore65 Lite: A Compact, Stable, and Durable Inductive Keyboard
-
Growing Up Spooky - Families Raised in America's Most Legendary Haunted Attractions
-
Looking for the Best Tax Advisors in Bangalore? Here’s Why Pyng Is the Right Choice
-
MorseLife Named a Fortune Media 2025 Best Workplace in Aging Services
-
DeFi crypto Mutuum Finance (MUTM) Onboards Over 17,300 Investors With 70% of Phase 6 Allocated
-
NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025
-
University of Phoenix College of Social and Behavioral Sciences Leadership Publishes White Paper on Trauma-Informed Education
-
Reconstruction and Opportunities: The CDFG Consumer White Paper 2024-2025 is Released
-
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical O
-
Andrew Left's Trial Begins -- Could Barry Honig Finally See Vindication?
-
Stop Believing Fake News: The Truth About MEXQuick and Scam Rumors
-
SurviveX Launches Tea-Tree-Infused Hydrogel Burn Dressings — Instant Cooling Relief with Professional-Grade Care
-
Masters Of Ring Entertainment Revolutionizes Professional Wrestling Industry with Triple Platform Launch
-
IDCXS Crypto Exchange Cuts Latency to Sub-Millisecond
-
Precede Biosciences Presents New ESMO 2025 Data Demonstrating Its Liquid Biopsy Platform’s Ability to Resolve Target Expression and Molecular Subtypes in Small Cell Lung Cancer
-
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Ba
-
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
-
Newfoundland and Labrador Victims and Survivors of Alcohol and Drug-Related Crashes Remembered at MADD Canada’s Annual Memorial Monument Ceremony
-
Nuvalent Presents Preliminary Data for Neladalkib in Advanced ALK-positive Solid Tumors Beyond NSCLC at ESMO 2025
-
Discover Our New Car Detailing Package
-
InvidiaTrade y TradingView se unen para ofrecer a los traders latinoamericanos una experiencia de analisis y ejecucion sin limites
-
ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreati
-
Oklahoma Plastic Surgeons Cements Reputation Among Best Tummy Tuck Surgeons in Oklahoma City Releasing Abdominalplasty Resource Library
-
/U P D A T E -- GRAIL, Inc./
-
Parental Control App for iPhone (2025): Qustodio Named Leading iPhone Safety App by Expert Consumers
-
Celcuity Presents Updated Data at the 2025 ESMO Congress from Phase 1 Study Evaluating Gedatolisib Plus Darolutamide in Men with Metastatic Castration Resistant Prostate Cancer (“mCRPC”)
-
Celcuity Provides Update on Status of the PIK3CA Mutated Cohort of Phase 3 VIKTORIA-1 Trial and Releases Additional Data Analysis From Phase 1b Clinical Trial
-
Detailed Results from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Trial Presented at 2025 ESMO Congress Demonstrate Potential for Gedatolisib Regimens to be Practice Changing for Patients with HR+/
-
New Partnership Enhances Contractor Exit Strategies
-
Rocky Hill Equipment Rentals Expands with New Location in Pflugerville, TX
-
Wendy Joy Inspires with Insights and Experiences
-
How to Build Real Instagram Followers on Instagram?
-
Kura Oncology Announces Preliminary Data from Its Farnesyl Transferase Inhibitor (FTI) Programs at the 2025 European Society for Medical Oncology (ESMO) Congress
-
The secrets to packing fragile items from Paso Robles self-storage
-
Central Pacific Construction announces Paso Robles pool contracting services
-
4Gs Plumbing unveils redesigned website with enhanced service details
-
Corbus Pharmaceuticals Presents CRB-701 Robust Clinical Responses in HNSCC and Cervical Cancers at ESMO25
-
Blazpay’s Phase 2 of Crypto Presale Surges With Over $250,000 Raised as XRP and Bitcoin Consolidate
-
Nurix Therapeutics Reports New Clinical Data from First-in-Class Oral CBL-B Inhibitor, NX-1607, Demonstrating Single-Agent Activity Across Multiple Tumor Types at the European Society for Medical Onco
-
Florida Cancer Specialists & Research Institute Shaping the Future of Cancer Care at Global Congress
-
Salubris Biotherapeutics Announces Dose Escalation Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the European Society for Medical Oncology 2025 Congress
-
General Oncology Announces Promising Preliminary Phase 1 Results from SHARON Trial Presented at ESMO 2025
-
Exelixis Announces Results from Subgroup Analysis of CABINET Phase 3 Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Advanced Lung and Thymic Neuroendocrine Tumors at ESMO 2025
-
Olema Oncology Announces New Data from the Phase 1b/2 Trial of Palazestrant Plus Ribociclib in ER+/HER2- Metastatic Breast Cancer at ESMO 2025
-
AdvanCell’s 212Pb-ADVC001 demonstrates encouraging safety and compelling anti-tumor activity in Phase 1b in prostate cancer
